1 year return (CAGR)
-10.21%
Crispr Therapeutics AG Exchange (NASDAQ, USD)
CRSP
55.76
-3.27 (-5.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
5.39%
5 year return (CAGR)
-13.81%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.39B
Price/Sales
402.60
Ent value
6.00B
Price/Book
3.09
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
4.10%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 59.10 |
| Daily high | 59.52 |
| Daily low | 54.67 |
| Daily Volume | 2.36M |
| All-time high | 210.04 |
| 1y analyst estimate | 87.56 |
| Beta | 1.76 |
| EPS (TTM) | -4.67 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Feb 2026 |
Downside potential
Loading...
Downside potential data
| CRSP | S&P500 | |
| Current price drop from All-time high | -73.45% | -1.29% |
| Highest price drop | -85.11% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -49.95% | -10.68% |
| Avg time to new high | 41 days | 12 days |
| Max time to new high | 1429 days | 1805 days |
News
